Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $49.1 million.

  • Medifast's Total Liabilities fell 3380.52% to $49.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $49.1 million, marking a year-over-year decrease of 3380.52%. This contributed to the annual value of $49.1 million for FY2025, which is 3380.52% down from last year.
  • According to the latest figures from Q4 2025, Medifast's Total Liabilities is $49.1 million, which was down 3380.52% from $53.5 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Total Liabilities registered a high of $211.1 million during Q2 2022, and its lowest value of $49.1 million during Q4 2025.
  • For the 5-year period, Medifast's Total Liabilities averaged around $126.4 million, with its median value being $130.1 million (2023).
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 6577.02% in 2021, then tumbled by 3957.03% in 2025.
  • Over the past 5 years, Medifast's Total Liabilities (Quarter) stood at $195.9 million in 2021, then dropped by 17.71% to $161.2 million in 2022, then tumbled by 32.72% to $108.4 million in 2023, then crashed by 31.66% to $74.1 million in 2024, then tumbled by 33.81% to $49.1 million in 2025.
  • Its Total Liabilities stands at $49.1 million for Q4 2025, versus $53.5 million for Q3 2025 and $53.3 million for Q2 2025.